日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2(+) breast cancer: TBCRC049 phase 2 study results

Tucatinib-trastuzumab-capecitabine治疗HER2(+)乳腺癌女性软脑膜转移:TBCRC049 II期研究结果

Murthy, Rashmi K; O'Brien, Barbara J; Berry, Donald A; Singareeka-Raghavendra, Akshara; Monroe, Maria Gule; Johnson, Jason; White, Jason; Schwartz-Gomez, Jill; Topletz-Erickson, Ariel; Lobbous, Mina; Riley, Kristen; Melisko, Michelle; Morikawa, Aki; Ferguson, Sherise D; de Groot, John F; Krop, Ian E; Valero, Vicente; Rimawi, Mothaffar F; Wolff, Antonio C; Tripathy, Debu; Lin, Nancy U; Stringer-Reasor, Erica M

Prognostic value of visually and computationally assessed tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer (TBCRC-030)

视觉和计算机评估的肿瘤浸润淋巴细胞在早期三阴性乳腺癌中的预后价值(TBCRC-030)

Nader-Marta, Guilherme; Chu, Xiangying; Mukhopadhyay, Satabhisa; Abramson, Vandana G; Brufsky, Adam; Stringer-Reasor, Erica Michelle; Dent, Susan Faye; Traina, Tiffany A; Carey, Lisa A; Rimawi, Mothaffar F; Specht, Jennifer M; Miller, Kathy D; Santa-Maria, Cesar Augusto; Dasgupta, Tathagata; Kurt, Busem Binboğa; DeMeo, Michelle; Krop, Ian E; Tung, Nadine M; Schnitt, Stuart J; Tayob, Nabihah; Mayer, Erica L

Identification of Early Symptoms Associated with Subsequent Immune-related Adverse Events in the I-SPY clinical trial

在 I-SPY 临床试验中识别与后续免疫相关不良事件相关的早期症状

Basu, Amrita; Umashankar, Saumya; Melisko, Michelle; Roy, Ritu; Yau, Christina; Pusztai, Lajos; Chien, A Jo; Liu, Minetta; Han, Hyo; Soliman, Hatem; Isaacs, Claudine; Shatsky, Rebecca; Stringer-Reasor, Erica; Robinson, Patricia; Yeung, Kay; Kalinsky, Kevin; Thomas, Alexandra; Philip, Errol; Musthafa, Mina; Hirst, Gillian; Asare, Adam; DeMichele, Angela; Van't Veer, Laura; Yee, Douglas; Hylton, Nola; Olshen, Adam; Perlmutter, Jane; Cohen, Ronald N; Quandt, Zoe; Esserman, Laura; Hershman, Dawn; Rugo, Hope; Nanda, Rita

Phase Ib Trial of Fulvestrant, Palbociclib, and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast Cancer

氟维司群、帕博西尼和厄达替尼(一种泛FGFR酪氨酸激酶抑制剂)治疗HR+/HER2-转移性乳腺癌的Ib期试验

Gonzalez-Ericsson, Paula I; Unni, Nisha; Jhaveri, Komal; Stringer-Reasor, Erica; Liu, Qi; Wang, Yu; Sanchez, Violeta; Garcia, Guadalupe; Sanders, Melinda E; Lehmann, Brian D; Balko, Justin M; Park, Ben; Rexer, Brent N; Mayer, Ingrid A; Arteaga, Carlos L

Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial

免疫亚型分析可识别对新辅助免疫疗法(IO)有反应的激素受体阳性早期乳腺癌患者:I-SPY2试验五个IO组的结果

Wolf, Denise M; Yau, Christina; Campbell, Michael; Glas, Annuska; Barcaru, Andrei; Mittempergher, Lorenza; Kuilman, Midas; Brown-Swigart, Lamorna; Hirst, Gillian; Basu, Amrita; Magbanua, Mark; Sayaman, Rosalyn; Huppert, Laura; Delson, Amy; Symmans, W Fraser; Borowsky, Alexander; Pohlmann, Paula; Rugo, Hope; Clark, Amy; Yee, Douglas; DeMichele, Angela; Perlmutter, Jane; Petricoin, Emmanuel F; Chien, Jo; Stringer-Reasor, Erica; Shatsky, Rebecca; Liu, Minetta; Han, Hyo; Soliman, Hatem; Isaacs, Claudine; Nanda, Rita; Hylton, Nola; Pusztai, Lajos; Esserman, Laura; van 't Veer, Laura

Therapeutic Clinical Trial Eligibility and Enrollment among Women with Breast Cancer: Implications for Understanding Trial Disparities

乳腺癌女性患者的治疗性临床试验入组资格和参与情况:对理解试验差异的启示

Reh, Nicole; Caston, Nicole E; Williams, Courtney P; Dwarampudi, Sindhu R; Elkhanany, Ahmed; Khoury, Katia; Stringer-Reasor, Erica; Jahan, Nusrat; Rocque, Gabrielle B; Gutnik, Lily A

Socioeconomic- and Insurance-Based Inequities in Oncotype DX Testing and Score-Guided Treatment

Oncotype DX 检测和评分指导治疗中存在的社会经济和保险不平等现象

Williams, Courtney P; Shuey, Jessica; El Dick, Joud; Jahan, Nusrat; Stringer-Reasor, Erica; Azuero, Andres; Rocque, Gabrielle B

A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer

一项随机II期临床试验,比较纳米白蛋白紫杉醇联合或不联合米非司酮治疗晚期三阴性乳腺癌的疗效

Chen, Nan; Matossian, Margarite; Saha, Poornima; Rampurwala, Murtuza; Kamaraju, Salaija; Hahn, Olwen; Howard, Frederick M; Fleming, Gini F; Freeman, Jincong Q; Karrison, Theodore; Conzen, Suzanne; Nanda, Rita; Stringer-Reasor, Erica M

Carboplatin, gemcitabine, and mifepristone for advanced breast and recurrent/persistent epithelial ovarian cancer

卡铂、吉西他滨和米非司酮用于治疗晚期乳腺癌和复发/持续性上皮性卵巢癌

Stringer-Reasor, Erica M; Saha, Poornima; Kocherginsky, Masha; Lastra, Ricardo; Baker, Gabrielle; Lenygel, Ernst; Karrison, Theodore; Olalde, Lauren; Mokrzycki, Elizabeth; Hahn, Olwen M; Hoffman, Philip C; Conzen, Suzanne D; Fleming, Gini F; Nanda, Rita

EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial)

EA1211:FDG-PET/CT 中期研究预测 HER2 阳性乳腺癌对新辅助治疗的反应(DIRECT 试验)

Hennessy, Maeve A; Gatsonis, Constantine; Jacene, Heather; Connolly, Roisin M; Burnette, Brian L; Stringer-Reasor, Erica M; Romanoff, Justin; Taurone, Alexander; O'Sullivan, Ciara C; Le-Petross, Huong T; Stearns, Vered; Fowler, Amy M; Tang, Shou-Ching; Sepulveda, Karla A; DeMichele, Angela M; Mankoff, David A; Wolff, Antonio C